AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2020 Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Abbott, Diagast, LabCorp & Siemens Healthineers - ResearchAndMarkets.com

February 4, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Feb 4, 2020--

The “2020 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, Strategic Profiles of Leading Competitors” report has been added to ResearchAndMarkets.com’s offering.

This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/3vrw1m

View source version on businesswire.com:https://www.businesswire.com/news/home/20200204005594/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 02/04/2020 08:27 AM/DISC: 02/04/2020 08:27 AM

http://www.businesswire.com/news/home/20200204005594/en